Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Latest filing published 18 Sept 2026 for GeneDx Holdings Corp.. Read the official filing
Filing timeline
BuySaleKevin Feeley
Insider track record
Disclosed buys
0
Disclosed sells
18
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kevin Feeley: trading record in brief
This profile gathers the share dealings of Kevin Feeley in GeneDx Holdings Corp., where the filings describe the role as finance chief. Between 1 December 2022 and 16 September 2026, the trades on record add up to 81 filings.
The open-market record consists of 18 sales worth €621k, with no purchase. The totals exclude 4 filings filed without an amount. Other entries cover 2 share grants and 61 option exercises. Since January 2026: no purchases and 12 sales on the market.
The newest entry dates from 18 September 2026: an open-market sale of €125k, in GeneDx Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin Feeley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations81 total
7,197 shares0Class A Common StockSEC:0001944119-26-000037:0
586 shares@ US$94.258Class A Common StockSEC:0001944119-26-000037:1
52 shares@ US$95.405Class A Common StockSEC:0001944119-26-000037:2
541 shares@ US$96.9009Class A Common StockSEC:0001944119-26-000037:3
1,470 shares@ US$98.27Class A Common StockSEC:0001944119-26-000037:4
1,079 shares@ US$98.995Class A Common StockSEC:0001944119-26-000037:5
2,462 shares0Class A Common StockSEC:0001944119-26-000035:0
1,285 shares@ US$84.21790.0042% mcap10.2% of flowClass A Common StockSEC:0001944119-26-000035:1
717 shares0Class A Common StockSEC:0001944119-26-000033:0
372 shares@ US$83.8390.0012% mcap3.3% of flowClass A Common StockSEC:0001944119-26-000033:1
7,197 sharesClass A Common StockSEC:0001944119-26-000031:0
760 sharesClass A Common StockSEC:0001944119-26-000031:1
2,106 sharesClass A Common StockSEC:0001944119-26-000031:2
863 sharesClass A Common StockSEC:0001944119-26-000031:3
2,462 sharesClass A Common StockSEC:0001944119-26-000029:0
1,266 sharesClass A Common StockSEC:0001944119-26-000029:1
754 shares0Class A Common StockSEC:0001944119-26-000024:0
392 shares@ US$65.19260.0012% mcap4.1% of flowClass A Common StockSEC:0001944119-26-000024:1
16,250 shares0Class A Common StockSEC:0001944119-26-000021:0
3,815 shares0Class A Common StockSEC:0001944119-26-000019:0
2,462 shares0Class A Common StockSEC:0001944119-26-000016:0
1,986 shares@ US$88.1118.1% of flowClass A Common StockSEC:0001944119-26-000014:0
15,262 shares0Class A Common StockSEC:0001944119-26-000011:0
718 shares0Class A Common StockSEC:0001944119-26-000008:0
754 shares0Class A Common StockSEC:0001944119-26-000006:0
25 of 81 declarations
